Form 4: Stryker Director Emmanuel Maceda Receives RSU Grant

Stryker Corporation director Emmanuel Perez Maceda was granted 762 restricted stock units as part of his compensation package.

Summary

• Director Emmanuel Perez Maceda received a grant of 762 restricted stock units (RSUs) on May 6, 2026.
• Each RSU represents a contingent right to receive one share of Stryker common stock.
• The RSUs are scheduled to vest on the earlier of the 2027 Annual Meeting of Shareholders or May 6, 2027.
• Following this transaction, the director's total beneficial ownership of Stryker common stock is 1,322 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• The value of the granted equity is subject to market fluctuations in Stryker Corporation's share price.

Future Outlook

The RSUs will vest in May 2027, contingent upon the director's continued service or the occurrence of the 2027 Annual Meeting.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard practice in the medical device industry to ensure long-term alignment with corporate performance and shareholder value.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard corporate governance practices among S&P 500 companies.
• The vesting period of approximately one year is typical for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 762 RSUs on or before May 6, 2027.

Key Dates

Keywords

Stryker, SYK, Director, Equity Grant, RSU, Insider Transaction, Corporate Governance